154 results

• Lawsuit Blames Mounjaro, Ozempic Side Effects for Vision Loss

  September 15, 2026

  Irvin Jackson

  A Louisiana man's lawsuit alleges several months of Mounjaro and Ozempic injections led to vision loss in his right eye.

• Lawsuit Alleges Ozempic Caused Sudden Eyesight Loss

  September 8, 2026

  Irvin Jackson

  An Ozempic NAION lawsuit blames the diabetes drug for a woman's sudden loss of vision and alleges the manufacturer failed to warn doctors of the risks.

• Ozempic NAION Lawsuit Filed Over Sudden, Permanent Vision Loss

  August 3, 2026

  Irvin Jackson

  A woman's Ozempic NAION lawsuit claims Novo Nordisk knew the GLP-1 drug carried a risk of vision loss, but refused to provide adequate label warnings.

• Link Between NAION and Ozempic, Wegovy Will Be Focus of Early Discovery in GLP-1 Vision Loss Lawsuits

  July 16, 2026

  Irvin Jackson

  A federal judge has called for early discovery in GLP-1 vision loss lawsuits to focus on "cross cutting" issues such as general causation and preemption claims.

• Wegovy Vision Side Effects Resulted in Blindness in Left Eye, Lawsuit Alleges

  June 16, 2026

  Irvin Jackson

  A Wegovy lawsuit claims the weight loss injections caused a rare disorder that attacks optic nerves, causing permanent vision loss.

• Mounjaro NAION Lawsuit Claims Side Effects Led to Permanent Vision Loss

  May 21, 2026

  Irvin Jackson

  A Mounjaro vision loss lawsuit accuses Eli Lilly of failing to properly investigate the drug's side effects and provide proper warnings before marketing it to the public.

• Ozempic and Mounjaro Drug Class Linked to 35% Higher NAION Vision Loss Risk

  May 14, 2026

  Irvin Jackson

  New research provides further evidence that Ozempic and similar drugs can increase the risk of a rare, but often permanent, form of vision loss.

• Ozempic Vision Loss Lawsuit Highlights Devastating Consequences of NAION Diagnosis

  May 4, 2026

  Irvin Jackson

  A Massachusetts man has filed an Ozempic vision loss lawsuit claiming the diabetes drug injections caused a condition that eroded his vision in both eyes.

• GLP-1 Dementia, Alzheimer’s Disease Risks Questioned in New Study

  April 27, 2026

  Irvin Jackson

  A new study finds cognitive decline in patients taking GLP-1 medications for longer than 10 years, yet researchers say it may be the result of those patients living longer than their peers.

• GLP-1 Wrongful Death Lawsuit Claims Compounder Sold Contaminated Meds

  April 15, 2026

  Irvin Jackson

  The family of a Texas woman who died from an alleged GLP-1 overdose after using a drug sold by a compounding pharmacy has filed a class action lawsuit, claiming the medication was defectively formulated and unreasonably dangerous.